Takeda Pharmaceutical Company Limited (TAK) SC 13D Calithera Biosciences / TAKEDA PHARMACEUTICAL ownership change

Exhibit 2

JOINT FILING AGREEMENT

In accordance with Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, the undersigned agree to the joint filing of a Statement on Schedule 13D (including any and all amendments thereto) with respect to the Common Stock of Calithera Biosciences, Inc. and further agree to the filing of this agreement as an Exhibit thereto. In addition, each party to this Agreement expressly authorizes each other party to this Agreement to file on its behalf any and all amendments to such Statement on Schedule 13D.

Dated: April 21, 2022

TAKEDA PHARMACEUTICAL COMPANY LIMITED
By	/s/ Yoshihiro Nakagawa
	Name:	Yoshihiro Nakagawa
	Title:	Corporate Officer, Global General Counsel

MILLENNIUM PHARMACEUTICALS, INC.
By	/s/ Paul Sundberg
	Name:	Paul Sundberg
	Title:	Attorney-in-fact